PATENT CLAIM ANALYSIS

Application Number: 15891051
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "133100"]

Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Claim (Index 19):
The antibody of any of  claims 1 - 13  that comprises all of SEQ ID NOs:\n 18, 21, 24, 29, 32, and 36.

Metadata:
- Claim Count in Document: 111.0
- Percentile: 88.0
- Lexical Diversity: 1.21212
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14729548', '14171330', '11996905', '15347171', '10449379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8135199793165209
- 35 USC 102 Novelty (BERT): 0.6158027416369918
- Combined Prediction Score: 0.793748255548568
- Mean Citation Score: 598.0016539999998
- Max Citation Score: 684.4663
- Similarity Product: 464.9981499846221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test